Terms: = Lymphoma AND STIL, SIL, 6491, ENSG00000123473, Q15468
424 results:
1. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
[TBL] [Abstract] [Full Text] [Related]
2. Williams-Beuren syndrome in pediatric T-cell acute lymphoblastic leukemia: A rare case report and review of literature.
Yang R; Ai Y; Bai T; Lu XX; He G
Medicine (Baltimore); 2024 Feb; 103(7):e36976. PubMed ID: 38363891
[TBL] [Abstract] [Full Text] [Related]
3. [Successful treatment with tucidinostat in a patient with relapsed adult T-cell leukemia/lymphoma following allogeneic hematopoietic stem cell transplantation].
Moriki A; Ito S; Horikita F; Tsutsumi Y
Rinsho Ketsueki; 2024; 65(1):18-23. PubMed ID: 38311384
[TBL] [Abstract] [Full Text] [Related]
4. Predictive factors and scoring system for intravascular large B-cell lymphoma among suspected cases: a single-center retrospective analysis.
Tanaka M; Miyagaki T; Okano T; Takeuchi S; Kadono T
Int J Dermatol; 2024 Jan; 63(1):79-84. PubMed ID: 37955167
[TBL] [Abstract] [Full Text] [Related]
5. Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever.
Kanda N; Yamaguchi R; Yamamoto Y; Matsumura M; Hatakeyama S
Sci Rep; 2023 Nov; 13(1):18784. PubMed ID: 37914769
[TBL] [Abstract] [Full Text] [Related]
6. Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation.
Zhang X; Wang T; Zhang Y; Wang F; Chen J; Ni J; Sun R; Wei Z; Zhang G; Li W; Li J; Lu P
Leuk Lymphoma; 2023 Dec; 64(13):2133-2139. PubMed ID: 37674391
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy.
Shirouchi Y; Nishimura N; Mishima Y; Ishihara Y; Asai H; Tamba M; Hirano M; Hirano K; Teramoto Y; Yoshida K; Takeuchi K; Terauchi T; Maruyama D
Sci Rep; 2023 Aug; 13(1):13713. PubMed ID: 37608029
[TBL] [Abstract] [Full Text] [Related]
8. Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study.
Kato N; Yamaguchi A; Sugata S; Hamada T; Furuya N; Mizumoto T; Tamaru Y; Kusunoki R; Kuwai T; Kouno H; Tazuma S; Sudo T; Kido M; Ito T; Kuraoka K; Kohno H
BMC Gastroenterol; 2023 May; 23(1):138. PubMed ID: 37127562
[TBL] [Abstract] [Full Text] [Related]
9. Real-world data from yttrium-90 ibritumomab tiuxetan treatment of relapsed or refractory indolent B-cell non-Hodgkin's lymphoma: J3Zi Study.
Choi I; Okada M; Ito T
Ann Hematol; 2023 May; 102(5):1149-1158. PubMed ID: 36995403
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical features of 19 patients with sil-TAL1-positive T-cell acute lymphoblastic leukemia].
Wang LJ; Chen Y; Xiang M; Yang XF; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Feb; 44(2):132-136. PubMed ID: 36948867
[No Abstract] [Full Text] [Related]
11. Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling.
Shah K; Al Ashiri L; Nasimian A; Ahmed M; Kazi JU
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902436
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of serum sil-2R and LDH levels in patients with intravascular large B-cell lymphoma and patients with advanced stage diffuse large B-cell lymphoma.
Hirami Y; Nishimura MF; Urata T; Morimoto M; Maekawa Y; Yoshino T; Nishimura Y; Sato Y
J Clin Exp Hematop; 2023 Mar; 63(1):25-31. PubMed ID: 36843068
[TBL] [Abstract] [Full Text] [Related]
13. Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL.
Mitobe Y; Matsuda KI; Sonoda Y
Neurol Med Chir (Tokyo); 2023 Mar; 63(3):111-115. PubMed ID: 36682790
[TBL] [Abstract] [Full Text] [Related]
14. TAL1 activation in T-cell acute lymphoblastic leukemia: a novel oncogenic 3' neo-enhancer.
Smith C; Goyal A; Weichenhan D; Allemand E; Mayakonda A; Toprak U; Riedel A; Balducci E; Manojkumar M; Pejkovska A; Mücke O; Sollier E; Bakr A; Breuer K; Lutsik P; Hermine O; Spicuglia S; Asnafi V; Plass C; Touzart A
Haematologica; 2023 May; 108(5):1259-1271. PubMed ID: 36632736
[TBL] [Abstract] [Full Text] [Related]
15. Miliary tuberculosis-associated hemophagocytic lymphohistiocytosis with a high level of soluble interleukin-2 receptor successfully treated with concomitant recombinant thrombomodulin: A case report.
Uryu H; Nakamura T; Nakashima D; Yamamoto K; Honda Y; Ishikawa M; Tsujita T; Hata N; Oinuma T; Yamazaki H; Yahagi Y
J Infect Chemother; 2023 Mar; 29(3):361-366. PubMed ID: 36481565
[TBL] [Abstract] [Full Text] [Related]
16. [Detection of Fusion Gene and Prognosis Analysis in Children with Acute Lymphoblastic Leukemia of Different Immunophenotypes].
Liu CY; Pan YS; Yang H; Hu X; Chen HY; Liu WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1673-1678. PubMed ID: 36476888
[TBL] [Abstract] [Full Text] [Related]
17. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma.
Suzuki K; Namba K; Kase S; Ogino Y; Hase K; Iwata D; Mizuuchi K; Hiraoka M; Kitaichi N; Ishida S
BMC Ophthalmol; 2022 Nov; 22(1):428. PubMed ID: 36357882
[TBL] [Abstract] [Full Text] [Related]
18. Mapping the genetic features of T-ALL cases through simplified NGS approach.
García-Aznar JM; Alonso S; Iglesias DU; de Ugarriza PL; López CÁ; Balbín M; Del Castillo TB
Clin Immunol; 2022 Dec; 245():109151. PubMed ID: 36270471
[TBL] [Abstract] [Full Text] [Related]
19. Primary Effusion lymphoma-like ATL Developing during Hemodialysis.
Masaki M; Okushi Y; Saito A; Fukuda A; Yamada S; Mizuta S; Masaki Y
Intern Med; 2023 Jun; 62(12):1807-1811. PubMed ID: 36261387
[TBL] [Abstract] [Full Text] [Related]
20. IgG4-related brain pseudotumor mimicking CNS lymphoma. A case report.
Oshima R; Ikeguchi R; Wako S; Mizuno T; Abe K; Nitta M; Muragaki Y; Kawamata T; Masui K; Yamamoto T; Shibata N; Shimizu Y; Kitagawa K
Neuropathology; 2022 Dec; 42(6):526-533. PubMed ID: 36210695
[TBL] [Abstract] [Full Text] [Related]
[Next]
